Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
KEYT 3 Santa Barbara· 2 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 2 hours agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...
What's Going On With Novavax Stock? - Novavax (NASDAQ:NVAX)
Benzinga· 2 days agoNovavax shares have gained nearly 40% over the past five days, boosted by COVID-19 headlines....
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 3 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 2 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
Will there be a new Covid vaccine in the fall?
NBC Universal via AOL· 2 days ago"Will we regret not having been a little bit closer...Pfizer said Wednesday it can have updated Covid shots available “immediately upon approval” from...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
KTBS Shreveport· 2 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday to recommend that the agency tell vaccine manufacturers to update the Covid ...
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
WSAU Wausau· 2 days ago(Reuters) - COVID-19 vaccine makers said data from animals studies showed their 2024-25 shots...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 hours agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Reuters via Yahoo News· 2 days agoThe 16 advisors did not vote on whether to favor the original JN.1 variant or one of its successors...
